Indications and uses
helps prevent sunburn if used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun
helps prevent sunburn if used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun
For sunscreen use: apply liberally 15 minutes before sun exposure use a water resistant sunscreen if swimming or sweating reapply at least every 2 hours children under 6 months: ask a doctor Sun protection measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF of 15 or higher-and other sun protection mea...
Protect this product from excessive heat and direct sun
Drug Facts
| Active ingredient(s) | Purpose |
|---|---|
| Titanium dioxide 15% | Sunscreen |
| Zinc oxide 5% | Sunscreen |
For external use only
Do not use on damaged or broken skin
When using this product keep out of eyes. Rinse with water to remove.
Stop use and ask a doctor if rash occurs
Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.
For sunscreen use:
lauroyl lysine, silica, calcium silicate. may contain: mica, titanium dioxide, iron oxides.
Protect this product from excessive heat and direct sun
Call toll free 1-888-795-4747
Dist. by Bare Escentuals Beauty, Inc., San Francisco, CA 94105, USA
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 98132-151-01 | bareMinerals Matte Foundation Broad Spectrum SPF 15 Golden Fair | 0.75 g in 1 JAR | POWDER | 0.75 | 2 | |
| 98132-151-02 | bareMinerals Matte Foundation Broad Spectrum SPF 15 Golden Fair | 1.5 g in 1 JAR | POWDER | 1.5 | 2 | |
| 98132-151-03 | bareMinerals Matte Foundation Broad Spectrum SPF 15 Golden Fair | 6 g in 1 JAR | POWDER | 6 | 2 | |
| 98132-152-01 | bareMinerals Matte Foundation Broad Spectrum SPF 15 Fairly Medium | 0.75 g in 1 JAR | POWDER | 0.75 | 2 | |
| 98132-152-02 | bareMinerals Matte Foundation Broad Spectrum SPF 15 Fairly Medium | 1.5 g in 1 JAR | POWDER | 1.5 | 2 | |
| 98132-152-03 | bareMinerals Matte Foundation Broad Spectrum SPF 15 Fairly Medium | 6 g in 1 JAR | POWDER | 6 | 2 | |
| 98132-154-01 | bareMinerals Matte Foundation Broad Spectrum SPF 15 Warm Dark | 0.75 g in 1 JAR | POWDER | 0.75 | 2 | |
| 98132-154-02 | bareMinerals Matte Foundation Broad Spectrum SPF 15 Warm Dark | 1.5 g in 1 JAR | POWDER | 1.5 | 2 | |
| 98132-154-03 | bareMinerals Matte Foundation Broad Spectrum SPF 15 Warm Dark | 6 g in 1 JAR | POWDER | 6 | 2 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 98132-151 | BAREMINERALS MATTE FOUNDATION BROAD SPECTRUM SPF 15 GOLDEN FAIR (TITANIUM DIOXIDE AND ZINC OXIDE) POWDER BAREMINERALS MATTE FOUNDATION BROAD SPECTRUM SPF 15 FAIRLY MEDIUM (TITANIUM DIOXIDE AND ZINC OXIDE) POWDER BAREMINERALS MATTE FOUNDATION BROAD SPECTRUM SPF 15 WARM DARK (TITANIUM DIOXIDE AND ZINC OXIDE) POWDER [BARE ESCENTUALS BEAUTY INC.] | 2 | Legacy NDC, 3 package rows | 20170322_ae69570e-67f7-43dd-ba6b-686dadafcbc9.zip |
| 98132-152 | BAREMINERALS MATTE FOUNDATION BROAD SPECTRUM SPF 15 GOLDEN FAIR (TITANIUM DIOXIDE AND ZINC OXIDE) POWDER BAREMINERALS MATTE FOUNDATION BROAD SPECTRUM SPF 15 FAIRLY MEDIUM (TITANIUM DIOXIDE AND ZINC OXIDE) POWDER BAREMINERALS MATTE FOUNDATION BROAD SPECTRUM SPF 15 WARM DARK (TITANIUM DIOXIDE AND ZINC OXIDE) POWDER [BARE ESCENTUALS BEAUTY INC.] | 2 | Legacy NDC, 3 package rows | 20170322_ae69570e-67f7-43dd-ba6b-686dadafcbc9.zip |
| 98132-154 | BAREMINERALS MATTE FOUNDATION BROAD SPECTRUM SPF 15 GOLDEN FAIR (TITANIUM DIOXIDE AND ZINC OXIDE) POWDER BAREMINERALS MATTE FOUNDATION BROAD SPECTRUM SPF 15 FAIRLY MEDIUM (TITANIUM DIOXIDE AND ZINC OXIDE) POWDER BAREMINERALS MATTE FOUNDATION BROAD SPECTRUM SPF 15 WARM DARK (TITANIUM DIOXIDE AND ZINC OXIDE) POWDER [BARE ESCENTUALS BEAUTY INC.] | 2 | Legacy NDC, 3 package rows | 20170322_ae69570e-67f7-43dd-ba6b-686dadafcbc9.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Titanium Dioxide | ACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| Zinc Oxide | ACTIVE INGREDIENT | SOI2LOH54Z | 1 | |
| Titanium Dioxide | ACTIVE MOIETY | 15FIX9V2JP | 1 | |
| Zinc Oxide | ACTIVE MOIETY | SOI2LOH54Z | 1 | |
| Calcium Silicate | INACTIVE INGREDIENT | S4255P4G5M | 1 | |
| Ferric Oxide Red | INACTIVE INGREDIENT | 1K09F3G675 | 1 | |
| LAUROYL LYSINE | INACTIVE INGREDIENT | 113171Q70B | 1 | |
| Mica | INACTIVE INGREDIENT | V8A1AW0880 | 1 | |
| Silicon Dioxide | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 98132-151 | 98132-151-01, 98132-151-02, 98132-151-03 |
| 98132-152 | 98132-152-01, 98132-152-02, 98132-152-03 |
| 98132-154 | 98132-154-01, 98132-154-02, 98132-154-03 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Titanium Dioxide | 15FIX9V2JP | ACTIB |
| Zinc Oxide | SOI2LOH54Z | ACTIB |
| LAUROYL LYSINE | 113171Q70B | IACT |
| Calcium Silicate | S4255P4G5M | IACT |
| Mica | V8A1AW0880 | IACT |
| Ferric Oxide Red | 1K09F3G675 | IACT |
| Silicon Dioxide | ETJ7Z6XBU4 | IACT |
| Titanium Dioxide | 15FIX9V2JP | ACTIB |
| Zinc Oxide | SOI2LOH54Z | ACTIB |
| LAUROYL LYSINE | 113171Q70B | IACT |
| Calcium Silicate | S4255P4G5M | IACT |
| Mica | V8A1AW0880 | IACT |
| Ferric Oxide Red | 1K09F3G675 | IACT |
| Silicon Dioxide | ETJ7Z6XBU4 | IACT |
| Titanium Dioxide | 15FIX9V2JP | ACTIB |
| Zinc Oxide | SOI2LOH54Z | ACTIB |
| LAUROYL LYSINE | 113171Q70B | IACT |
| Calcium Silicate | S4255P4G5M | IACT |
| Mica | V8A1AW0880 | IACT |
| Ferric Oxide Red | 1K09F3G675 | IACT |
| Silicon Dioxide | ETJ7Z6XBU4 | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 336 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER, FOR SOLUTION / ORAL | 280 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, FOR SOLUTION / ORAL | 1.8 mg/120ml | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | FILM, EXTENDED RELEASE / TRANSDERMAL | 49 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | SUSPENSION / ORAL | 400 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER, FOR SUSPENSION / ORAL | 2553 mg | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | CAPSULE / ORAL | 5 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TAMPON / VAGINAL | NA | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, DELAYED RELEASE / ORAL | 1190 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, DELAYED RELEASE PARTICLES / ORAL | 170 mg | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | TABLET, CHEWABLE / ORAL | 2 mg | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | TABLET, COATED / ORAL | 1 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, EXTENDED RELEASE / ORAL | 450 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE / ORAL | 5000 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE / ORAL | 300 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, COATED / ORAL | 176 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / TOPICAL | 6 mg | ||
| Calcium Silicate | CALCIUM SILICATE | S4255P4G5M | TABLET, FILM COATED / ORAL | 731 mg | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | TABLET, FILM COATED / ORAL | 3 mg | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | LOTION / TOPICAL | NA | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | FILM, SOLUBLE / ORAL | 2 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CREAM / VAGINAL | 51 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, ORALLY DISINTEGRATING / ORAL | 68 mg | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | DROPS / ORAL | NA | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, FOR SUSPENSION / ORAL | 220 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, COATED / ORAL | 3 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | SUSPENSION, EXTENDED RELEASE / ORAL | 70 mg | ||
| Calcium Silicate | CALCIUM SILICATE | S4255P4G5M | TABLET, COATED / ORAL | 155 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, CHEWABLE / ORAL | 254 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | DROPS / ORAL | NA | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER / RESPIRATORY (INHALATION) | NA | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | SUPPOSITORY / RECTAL | 14 mg | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | TABLET, ORALLY DISINTEGRATING / ORAL | 2 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | SYSTEM / TRANSDERMAL | 35 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | INSERT / VAGINAL | 8 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, COATED PELLETS / ORAL | 69 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / BUCCAL | 3 mg | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | CREAM / TOPICAL | NA | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / DENTAL | 19 %w/w | ||
| Calcium Silicate | CALCIUM SILICATE | S4255P4G5M | TABLET, EXTENDED RELEASE / ORAL | 15 mg | ||
| Calcium Silicate | CALCIUM SILICATE | S4255P4G5M | TABLET, ORALLY DISINTEGRATING / ORAL | 600 mg | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | POWDER, FOR SUSPENSION / ORAL | 1 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | SOLUTION / ORAL | 336 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | LOZENGE / ORAL | 120 mg | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | CAPSULE, EXTENDED RELEASE / ORAL | 5 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, EXTENDED RELEASE / ORAL | 168 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / ORAL | 750 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, LIQUID FILLED / ORAL | 106 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 69 mg | ||
| Calcium Silicate | CALCIUM SILICATE | S4255P4G5M | CAPSULE / ORAL | 40 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / SUBLINGUAL | 10 mg | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | TABLET, DELAYED RELEASE / ORAL | 37 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / VAGINAL | 8 %w/w | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | PASTE / DENTAL | 34 %w/w | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, DELAYED RELEASE / ORAL | 40 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 2 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / NASAL | 20 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, FILM COATED / ORAL | 166 mg | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | TABLET / SUBLINGUAL | 1 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 70917078-7a5b-4f3c-862c-ebf0dd893153 | ae69570e-67f7-43dd-ba6b-686dadafcbc9 | 2017-03-15 | Warnings | 70917078-7a5b-4f3c-862c-ebf0dd893153 ae69570e-67f7-43dd-ba6b-686dadafcbc9 |
Adverse event summaries are temporarily unavailable. Other product information remains available.